4.6 Article

Comparable effectiveness of 45-and 20-min post-infusion scalp cooling time in preventing paclitaxel-induced alopecia - a randomized controlled trial

Related references

Note: Only part of the references are listed.
Article Oncology

Dear hair loss-illness perceptions of female patients with chemotherapy-induced alopecia

Anne Versluis et al.

Summary: Objective Chemotherapy-induced alopecia (CIA) is a common and distressing side effect of chemotherapy treatment. This study aimed to assess the illness perceptions of female patients dealing with CIA and their associations with various factors. The results indicated that patients understood their hair loss but lacked understanding of managing it, negatively impacting their lives. The study also compared the illness perceptions of patients with CIA to other samples and found that patients with CIA felt less able to manage their hair loss.

SUPPORTIVE CARE IN CANCER (2022)

Article Oncology

Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres

Joachim Chan et al.

Summary: This study investigated the prevalence and patterns of permanent chemotherapy-induced alopecia (pCIA) resulting from docetaxel and paclitaxel chemotherapy, with docetaxel being significantly more prevalent in causing pCIA compared to paclitaxel.

EUROPEAN JOURNAL OF CANCER CARE (2021)

Article Oncology

Digital Innovation in Oncological Primary Treatment for Well-Being of Patients: Psychological Caring as Prompt for Enhancing Quality of Life

Dina Di Giacomo et al.

Summary: The digitised scalp cooling systems play an important role in preventing chemotherapy-induced alopecia and enhancing patients' mental health during chemotherapy. The study conducted two research protocols to investigate the emotional impact of using scalp cooling technology among oncological patients with breast cancer, as well as the effectiveness of scalp cooling in managing hair loss.

CURRENT ONCOLOGY (2021)

Article Oncology

Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention

Cynthia Villarreal-Garza et al.

Summary: This study evaluated the effectiveness of scalp cooling (SC) among breast cancer patients receiving different chemotherapy regimens. Results showed that SC was highly effective in preventing alopecia, particularly with taxane-based regimens. The sequence of chemotherapy administration may have a significant impact on the success of SC for preventing hair loss.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Review Oncology

The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review

Dustin H. Marks et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Article Medicine, General & Internal

Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer

Hope S. Rugo et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Medicine, General & Internal

Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer The SCALP Randomized Clinical Trial

Julie Nangia et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Review Oncology

Treatment regimens of classical and newer taxanes

Markus Joerger

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)

Article Oncology

No effect of scalp cooling on survival among women with breast cancer

J. Lemieux et al.

BREAST CANCER RESEARCH AND TREATMENT (2015)

Article Oncology

Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia

Corina J. van den Hurk et al.

ACTA ONCOLOGICA (2014)

Article Oncology

Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia

C. J. G. van den Hurk et al.

SUPPORTIVE CARE IN CANCER (2012)

Article Oncology

Impact of alopecia and scalp cooling on the well-being of breast cancer patients

Corina J. G. van den Hurk et al.

PSYCHO-ONCOLOGY (2010)